And this often is a form factor as you outlined or it could be dosing dynamics of a patient is not getting the outcome that theyre hoping for, are they experiencing side effects that are intolerable
He has received grant support from AstraZeneca, Eli Lilly & Co., Menarini/Berlin-Chemie, Merck, Sharp & Dohme, Novartis Pharma, and Novo Nordisk
There are considerable risks involved, including the risk of messing up your dose or of using compounded medications, which are not FDA approved for safety, quality, or efficacy, says Zimmermann
Consistency and pairing with the right co-actives drive results
Prevalence of gastrointestinal symptoms in patients with type 2 diabetes: a population-based study